Skip to main content
. Author manuscript; available in PMC: 2019 Jan 8.
Published in final edited form as: ChemMedChem. 2018 Nov 26;13(24):2606–2617. doi: 10.1002/cmdc.201800598

Figure 2.

Figure 2.

Anti-proliferative activity of CAB-NE3TA (10 μM) and DFO (10 μM) against cancer cells. The compound was incubated with the cells for 72 h, and cell viability was determined using MTS assay. The reported data on the anti-proliferative activity of the known compound DFO against HeLa, HT29, and PC3 are included for comparison [17,22].